Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy. (2020)

• Record Type: Journal Article
• Authors: Geisen, Will R.; Berger, Justin; Schwartz, Chelsea; Reddy, Abhimanyu; Rai, Balaj; Wadih, George; Peck, Joshua
• Is Part Of: IDCases. Volume 22(2020)
• Publication Date: 2020
• Subjects: COVID-19 -- Immunocompromised -- Colitis -- Endoscopy; Communicable diseases -- Periodicals; Communicable Diseases -- Case Reports; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1016/j.idcr.2020.e00962
• Languages: English
• ISSNs: 2214-2509

Abstract

Abstract: The novel coronavirus-2019 (COVID-19) has caused a global pandemic of historical proportions, infecting millions of people worldwide. Due to its high mortality rate and a paucity of clinical data, experimental therapies have been utilized with uncertain success and, unfortunately, poor outcomes. We describe a gentleman who was treated with experimental therapies and subsequently developed cytomegalovirus colitis and hypovolemic shock. Additionally, this case validates colonoscopy as a mode to rule out concurrent infectious etiologies causing diarrhea in COVID-19-positive patients.